Landscapes / Targets
IL-2R
7 drugs act on IL-2R, in 8 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs7
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 1/2 | Dec 2026Phase 1/2 trial completes | |||
| Next date | Dec 2026 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumor | ||||
| Open drug page | |||||
— |
Sanofi · Public SNY |
Phase 1/2 | 13 Sep 2027Phase 1/2 trial completes | ||
| Next date | 13 Sep 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Plasma Cell Myeloma Refractory | ||||
| Open drug page | |||||
— |
Phase 1/2 | — | |||
| Also tested for | Advanced Solid Tumor | ||||
| Open drug page | |||||
— |
Phase 1 | 1 Jul 2027Phase 1 trial completes | |||
| Next date | 1 Jul 2027 · Phase 1 trial completes | ||||
| Also tested for | Adult Solid Tumor | ||||
| Open drug page | |||||
— |
Phase 1 | Jan 2029Phase 1 trial completes | |||
| Next date | Jan 2029 · Phase 1 trial completes | ||||
| Also tested for | Advanced Cancer, Advanced Cancers (Solid Tumors) | ||||
| Open drug page | |||||
— |
Hanmi · Public 128940.KS |
Phase 1 | Jul 2031Phase 1 trial completes | ||
| Next date | Jul 2031 · Phase 1 trial completes | ||||
| Also tested for | Advanced or Metastatic Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Advanced Cancer, Solid Tumor and 1 more | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 7 of 7 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026